Cargando…
Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria
Multidrug-resistant (MDR) Gram-negative bacteria are the top-priority pathogens to be eradicated. Drug repurposing (e.g., the use of non-antibiotics to treat bacterial infections) may be helpful to overcome the limitations of current antibiotics. Zidovudine (azidothymidine, AZT), a licensed oral ant...
Autores principales: | Cho, Hyejin, Kim, Kwang-sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950944/ https://www.ncbi.nlm.nih.gov/pubmed/35335928 http://dx.doi.org/10.3390/pharmaceutics14030552 |
Ejemplares similares
-
Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates
por: Kontou, Angeliki, et al.
Publicado: (2023) -
Toward Repurposing Ciclopirox as an Antibiotic against Drug-Resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae
por: Carlson-Banning, Kimberly M., et al.
Publicado: (2013) -
Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent
por: Feng, Hongxuan, et al.
Publicado: (2020) -
Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)